TherapeuticsMD (TXMD) Shares Outstanding (2010 - 2026)

TherapeuticsMD's Shares Outstanding (Entity) history runs 16 years deep, the most recent figure standing at $136000.0 for Q1 2026.

• Quarterly Shares Outstanding (Entity) fell 98.82% year-over-year to $136000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $136000.0 (down 98.82% YoY) and the FY2025 annual result came in at $11.6 million, up 100264.2% from the prior year.
• Shares Outstanding (Entity) was $136000.0 for Q1 2026 at TherapeuticsMD, down from $11.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $11.6 million in Q1 2025 and bottomed at $11532.0 in Q4 2024.
• A 5-year average of $9.4 million and a median of $10.6 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) slumped 99.9% — and 2025, when it surged 100264.2%.
• TherapeuticsMD's Shares Outstanding (Entity) stood at $9.5 million in 2022, then advanced by 21.42% to $11.5 million in 2023, then slumped by 99.9% to $11532.0 in 2024, then jumped by 100264.2% to $11.6 million in 2025, then tumbled by 98.82% to $136000.0 in 2026.
• Business Quant data shows TXMD's Shares Outstanding (Entity) at $136000.0 in Q1 2026, $11.6 million in Q4 2025, and $11.6 million in Q3 2025.